EHCNYSEServices-HospitalsFiscal year ends December 31
Encompass Health Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$121.71−6.16 (-4.82%)
Close on Oct 19, 2026
- Market cap
- $12.17B
- P/E (TTM)
- 19.8
- Dividend yield
- 0.59%
Share price
−$2.84 (−2.28%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
Encompass Health Corp grew revenue 9.5% to $6.21B over the twelve months to Jun 30, 2026. Free cash flow was $413.40M, down 5.9% from a year earlier.
Revenue
$6.21B
+9.5% vs. a year earlier
Free cash flow
$413.40M
-5.9% vs. a year earlier
EPS, diluted
$6.14
+20.2% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $12.17B
- P/E ratio
- 19.8
- Price to sales
- 1.96
- Price to book
- 4.69
- Dividend yield
- 0.59%
- Free cash flow yield
- 3.40%
Fundamentals
- Revenue
- $6.21B
- Net income
- $621.00M
- EPS, diluted
- $6.14
- Free cash flow
- $413.40M
- Book value per share
- $25.98
- Diluted shares
- 100M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$6.21B+9.5% YoY
Operating income
–
Net income
$621.00M+18.8% YoY
EPS, diluted
$6.14+20.2% YoY
Free cash flow
$413.40M-5.9% YoY
Reported periodTrailing twelve months